New registry aims to uncover hidden liver risks in diabetes patients

NCT ID NCT07437157

First seen Feb 28, 2026 · Last updated May 10, 2026 · Updated 8 times

Summary

This study will follow 1000 adults with type 2 diabetes and fatty liver disease to understand how these conditions progress over time. Researchers will collect health data and blood samples to find markers that predict serious liver problems. The goal is to improve monitoring and prevent complications like liver failure or heart disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital

    RECRUITING

    Hong Kong, New Territories, 99977, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.